Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2017 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The transcript discusses various programs, but the question is about the company's own repeatable business escalating in unit size. The company is a shipbuilder. They talk about programs like LPD, DDG, carriers, submarines. They mention that LPD 29 is a step, but they need LXR to follow. They talk about increasing production rates (e.g., Virginia class to three per year, DDG surge). But that is about volume, not necessarily unit size. They also talk about buying carriers two at a time, which is about contracting multiple ships, but that's not necessarily larger unit size per ship. The question is about the size of each engagement (e.g., each contract, each order) being larger than before. For example, if they used to sell one ship per contract and now sell two, that could be larger. But they mention "buying carriers two at a time" as a more efficient way, but that's about procurement strategy, not necessarily that each contract is larger. They also talk about LPD 29 being a bridge, but not that it's larger than previous LPDs. They don't explicitly say that the size of each new contract is larger than before. They talk about increasing volume, but not unit size. They also mention that the 2017 budget is up 15% from Obama's request, but that's about overall budget, not unit size. The question is specific: "successive engagements of the same kind are coming in at progressively larger size" meaning each new deal is bigger than the last for the same offering. I don't see that in the transcript. They talk about more ships, but not that each ship contract is bigger. They also talk about the need for LXR to follow LPD, but that's about continuity, not size. They mention that they are investing in capital to support increased production, but that's about capacity. No mention of average order size increasing. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.